AIM
MRNA icon

Aquila Investment Management’s Moderna MRNA Stock Holding History

Aquila Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,000
Closed -$356K – 71
2024
Q2 		$356K Hold
3,000
– – 0.33% 58
2024
Q1 		$320K Hold
3,000
– – 0.27% 65
2023
Q4 		$298K Buy
+3,000
New +$252K 0.26% 79

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aquila Investment Management's MRNA Position: Q3 2024 in Review

Aquila Investment Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 3,000 shares — an estimated $356K sold.

Aquila Investment Management first reported a position in MRNA in Q4 2023 and held it in 3 quarters. The position peaked at $356K in Q2 2024. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Aquila Investment Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Aquila Investment Management sold 3,000 Moderna shares in Q3 2024, an estimated $356K.
  • Aquila Investment Management first reported a position in Moderna in Q4 2023 and held it in 3 quarters.
  • Aquila Investment Management's Moderna position peaked at $356K in Q2 2024.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Aquila Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.